AGP Executive Report
Last update: 8 hours agoCBD Markets: MediPharm Labs has launched a full-spectrum CBD oral oil in Brazil after receiving ANVISA authorization, expanding access in one of the world’s tightly regulated medical cannabinoid markets. Hemp Rules: U.S. hemp businesses face renewed uncertainty as federal THC restrictions loom and the FDA remains late on required guidance; retailers and producers are preparing for potential disruption. Medical Access: South Africa’s Section 21 cannabis freeze is raising concerns about patient access, while an Indian research project aims to develop medicinal products for cancer and epilepsy. In Australia’s ACT, a committee advised against a proposed roadside-testing exemption for medicinal cannabis patients for now, citing unresolved road-safety concerns. Health Research: A UCLA study found occasional cannabis users reported different effects by sex, with men experiencing stronger intoxication and impairment; researchers say more work is needed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
